Poster Exhibition 1

[PE-131] Efficacy and safety of subcutaneous guselkumab induction therapy in patients with ulcerative colitis: Results through week 12 from the phase 3 ASTRO study

*TADAKAZU HISAMATSU¹, Laurent Peyrin-Biroulet², Jessica R. Allegretti³, Silvio Danese⁴, Matthew Germinaro⁵, Thomas Baker⁵, Yelina Alvarez⁵, Silke Jörgens⁵, Lingjing Jiang⁵, Hongyan Zhang⁵, David T. Rubin⁶, Millie Long⁷ (1. Kyorin University School of Medicine, Tokyo, Japan, 2. University of Lorraine, Inserm, NGERE, F-54000 Nancy, France and Groupe Hospitalier privé Ambroise Paré-Hartmann, Paris IBD Centre, 92200 Neuilly sur Seine, France, 3. Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA, 4. Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy, 5. Janssen Research & Development, LLC, Spring House, PA, USA, 6. University of Chicago Medicine Inflammatory Bowel Disease Centre, Chicago, IL, USA, 7. Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.